ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1341	National Cancer Institute	Html	en	Smokeless Tobacco and Cancer	A fact sheet about the health risks associated with the use of smokeless tobacco.	tobacco cut size 0.465919 NCI smoking cessation 0.353151 safe level 0.345736 oral tobacco 0.470575 nicotine addiction 0.363201 Human Services 0.340767 Health State-of-the-Science conference 0.343313 U.S. Department 0.340786 tobacco-specific nitrosamines 0.373338 tobacco fertilizer 0.451995 advisory committee 0.346137 powdered tobacco 0.462627 Health Organization International 0.342988 oral cancer 0.332186 National Institutes 0.343448 Watson C. Surveillance 0.3381 Tobacco Control Monograph 0.451686 moist snuff 0.436686 precancerous white patches 0.344838 International Agency 0.339252 NCI’s Smoking 0.334129 Tobacco Research 0.437462 NCI fact sheet 0.385333 lower lip 0.34967 esophageal cancer 0.332063	nicotine stays 0.353085 Yes. All tobacco 0.450832 National Cancer Institute 0.373261 LiveHelp online chat 0.341688 American snuff 0.346643 polynuclear aromatic hydrocarbons 0.347124 Eastern time 0.340428 spitting tobacco 0.470917 online text chat 0.340605 polycyclic aromatic hydrocarbons 0.346589 smokeless tobacco products 0.615213 smokeless tobacco cause 0.576883 Nicotine content 0.350271 un-ionized nicotine 0.348074 Surgeon General 0.344959 smokeless tobacco 0.995709 Yes. Smokeless tobacco 0.55885 dry snuff 0.363969 noncancerous oral conditions 0.343638 NIH State-of-the-Science Panel 0.338818 tobacco cause cancer 0.483342 smoking cessation counselor 0.38611 tobacco juices 0.469352 harmful chemicals 0.350583	CLICK HERE
1364	National Cancer Institute	Html	en	Sleep Disorders (PDQ®)–Health Professional Version	Expert-reviewed information summary about causes and management of sleep disorders in people with cancer.	slow wave sleep 0.645037 sleep difficulty 0.586858 circadian sleep disorder 0.585999 sleep disturbance 0.734742 general sleep 0.627531 self-reported sleep 0.586211 sleep disturbances 0.78937 sleep environment 0.599417 general sleep hygiene 0.610843 sleep history 0.590036 poor sleep hygiene 0.618457 sleep patterns 0.707388 individual sleep patterns 0.650508 sleep cycle. 0.613137 sleep diary 0.632064 subjective sleep quality 0.612249 sleep disruption 0.616368 severe sleep 0.619271 sleep medicine report 0.579291 Pittsburgh Sleep Quality 0.612644 8-hour sleep period. 0.649042 General Sleep Disturbance 0.626985 different sleep trajectories 0.61732 secondary sleep disorders 0.654958	behavioral therapy 0.643973 cancer experience sleep 0.697426 numerous sleep parameters 0.602184 sleep education 0.598942 REM sleep 0.663854 sleep 0.906331 diary-measured sleep variables 0.59623 sleep cycle 0.621195 sleep outcomes 0.569139 sleep medicine 0.672639 common sleep disturbance 0.63638 total sleep time 0.611253 sleep quality 0.73817 sleep disorders 0.662401 progressively deepening sleep 0.64769 Adequate sleep 0.615183 sleep restriction 0.71475 severe sleep disturbances 0.604554 breast cancer 0.670406 insomnia 0.65868 randomized controlled trial 0.60112 severe sleep disorder 0.613455 sleep hygiene 0.685071 NREM sleep 0.616861	CLICK HERE
1463	National Cancer Institute	Html	en	Renal Cell Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of renal cell cancer.	2-week washout period 0.566416 Transitional Cell Cancer 0.481465 treatment 0.601534 Patient Preference Study 0.474292 sunitinib treatment 0.529856 10-week treatment period 0.482517 VEGF receptors 0.467264 well-differentiated renal adenocarcinomas 0.509726 pazopanib arm 0.470964 sunitinib side effects 0.517044 true treatment break 0.474342 primary endpoint 0.499973 patients preferred pazopanib 0.531227 immediately surrounding tissue 0.462945 6-week treatment cycle 0.515867 trial 0.472067 Late tumor recurrence 0.47026 Pazopanib Versus Sunitinib 0.55357 cytoreductive nephrectomy extends 0.466923 High-dose IL-2 0.463042 patient treatment 0.463771 occasional selected patients 0.50375 overall survival 0.481487 rating scale 0.463587	toxic effects 0.499682 axitinib versus sorafenib 0.467683 sorafenib patients 0.470445 sunitinib 0.625595 renal cell cancer 0.570239 recurrent renal cell 0.504482 metastatic disease 0.476849 external-beam radiation therapy 0.463579 patients 0.74513 Metastatic Kidney Cancer 0.465785 initial cytoreductive nephrectomy 0.466065 median PFS time 0.4636 renal adenomas 0.481736 4-week treatment cycle 0.477666 renal cell carcinoma 0.969838 renal cell carcinoma. 0.553709 transitional cell carcinomas 0.485832 clear-cell renal cell 0.607225 renal cell cancers 0.532142 renal pelvis 0.520062 10-week treatment periods 0.476333 metastatic renal cell 0.598995 renal cell carcinomas 0.527788	CLICK HERE
1524	National Cancer Institute	Html	en	Endometrial Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of endometrial cancer.	cancer treatment 0.541916 Lymph node dissection 0.478324 metastatic endometrial cancer 0.510561 body 0.511838 PDQ cancer information 0.531329 clinical trial search 0.465384 uterus 0.585793 endometrial cancer spreads 0.509404 mTOR inhibitors 0.464666 clinical trials 0.736061 cancer information summary 0.508345 clinical trial 0.5843 Low-risk endometrial cancer 0.501844 breast cancer patients 0.483969 patients 0.494506 NCI PDQ cancer 0.479485 malignant tumor cells 0.467809 lymph nodes 0.52827 endometrial hyperplasia 0.468477 radiation therapy 0.605187 Treatment Editorial Board 0.469208 endometrial cancer 0.889926 radical hysterectomy 0.471844 treatment 0.622425 cancer prevention 0.463817	new cancer treatments 0.470535 NCI-supported cancer 0.463476 cancer cells 0.753566 Cancer Information Service 0.471559 specific cancer cells 0.479989 treatment clinical trials 0.48357 High-risk endometrial cancer 0.500552 endometrial tissue 0.464689 National Cancer Institute 0.508844 new treatment 0.504217 cervix 0.474629 external radiation therapy 0.482834 non-polyposis colon cancer 0.477796 tissue samples 0.463584 cancer research process 0.465542 cancer clinical trials 0.501833 stage 0.522219 Endometrial Cancer Treatment 0.516218 Recurrent endometrial cancer 0.629078 fallopian tubes 0.494755 cancer information summaries 0.469865 treatment options 0.466033 comprehensive cancer information 0.469896 internal radiation therapy 0.504839	CLICK HERE
1587	National Cancer Institute	Html	en	Childhood Rhabdomyosarcoma Treatment (PDQ®)–Patient Version	Treatment of children with rhabdomyosarcoma often includes chemotherapy, radiation therapy, and surgery. Learn about the signs, tests to diagnose, survival, treatment, and clinical trials for children with rhabdomyosarcoma in this expert-reviewed summary.	cancer treatment 0.508808 alveolar tumor 0.397789 tissue 0.446976 body 0.557677 type 0.525643 chemotherapy 0.500597 PDQ cancer information 0.443489 childhood rhabdomyosarcoma 0.648755 stereotaxic radiation therapy 0.400999 embryonal tumor 0.43303 clinical trials 0.703451 rhabdomyosarcoma 0.676649 nearby lymph nodes 0.746635 cancer information summary 0.418411 rhabdomyosarcoma cells 0.404898 clinical trial 0.53997 sentinel lymph node 0.434722 malignant tumor cells 0.470546 body radiation therapy 0.454423 lymph nodes 0.791456 radiation therapy machine 0.400658 radiation therapy 0.98278 beam radiation therapy 0.399186 soft tissue sarcoma 0.440069	treatment 0.729346 wide local excision 0.482565 cancer cells 0.726714 Conformal radiation therapy 0.416835 treatment clinical trials 0.409517 stereotactic body radiation 0.441552 National Cancer Institute 0.429355 spinal cord 0.406531 metastatic rhabdomyosarcoma 0.428908 effects cancer treatment 0.408271 new treatment 0.425898 Intensity-modulated radiation therapy 0.401599 external-beam radiation therapy 0.401022 external radiation therapy 0.507659 primary tumor 0.410338 metastatic tumor 0.420784 Childhood Rhabdomyosarcoma Treatment 0.412835 bone marrow 0.399523 cancer clinical trials 0.406325 interstitial radiation therapy 0.400167 tumor 0.799626 recurrent rhabdomyosarcoma 0.413207 internal radiation therapy 0.435661 cancer 0.935623	CLICK HERE
1636	National Cancer Institute	Html	en	Cartilage (Bovine and Shark) (PDQ®)–Patient Version	Expert-reviewed information summary about the use of bovine and shark cartilage as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	cancer treatment 0.483107 human cancer cells 0.399726 cartilage treatment 0.54785 shark cartilage 0.911115 PDQ cancer information 0.489648 Cancer Complementary 0.397259 lung cancer 0.396037 new blood vessels 0.529873 blood vessel growth 0.688109 clinical trials 0.661965 testing bovine cartilage 0.553086 powdered cartilage products 0.528871 bovine cartilage 0.754583 cancer information summary 0.450971 clinical trial 0.545778 patients 0.414137 randomized clinical trial 0.405563 NCI PDQ cancer 0.409125 cancer information database 0.395004 liquid shark cartilage 0.530016 liquid cartilage products 0.569642 powdered shark cartilage 0.613657 cancer information 0.501779 breast cancer cells 0.394321	shark cartilage products 0.633195 laboratory study 0.408409 cartilage products 0.782377 Complementary Therapies Editorial 0.405419 cancer cells 0.530307 Cancer Information Service 0.450397 preclinical studies 0.47111 cartilage product AE–941/Neovastat 0.510074 dietary supplements 0.394341 National Cancer Institute 0.540172 studies 0.47228 alternative medicine 0.440784 pancreatic cancer cells 0.3965 human cartilage 0.495387 PDQ Cartilage 0.50056 shark cartilage product 0.665863 cartilage 0.96677 animal studies 0.448189 standard cancer treatment 0.405448 alternative therapies 0.399716 cancer information summaries 0.395389 powdered cartilage 0.59313 bovine cartilage product 0.523261 cancer 0.811115	CLICK HERE
1918	National Cancer Institute	Html	es	Tratamiento del cáncer de vías biliares (colangiocarcinoma) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vías biliares.	pequeñas incisiones 0.429743 siguientes procedimientos 0.496942 pequeño número 0.430642 estadio iv 0.806715 IIIB.Estadio IIIA 0.428895 siguientes afecciones 0.443112 siguientes tipos 0.469726 múltiples tumores 0.426811 rayos x 0.429804 estadio ivb 0.620663 llama estadificación 0.509816 vías extrahepáticas distal 0.500664 rama derecha 0.425053 biliares extrahepáticas distal 0.562053 estadio iva 0.611281 quimioterapia sistémica 0.540152 National Cancer Institute 0.425091 quimioterapia sistémica ayuda 0.448855 colangiocarcinomas.ampliar anatomía 0.433411 estadios iiia 0.428062	siguientes riesgos 0.418955 estadio iib.estadio iia 0.483131 Instituto Nacional 0.443118 PDQ Tratamiento 0.452416 siguientes grupos 0.435798 vías biliares.Cáncer 0.522502 Colangiopancreatografía retrógrada 0.432583 marcador tumoral ca 0.457024 color arcilla 0.428813 fosfatasa alcalina 0.43337 siguientes factores 0.436523 partes distantes 0.435203 Physician Data Query 0.487514 estadio ib.estadio ia 0.481572 estadio iii 0.699586 antígeno carcinoembrionario 0.500245 biliar extrahepático distal 0.995606 medicamentos radiosensibilizadores 0.497933 pequeños conductos 0.46338 estadio ivb.estadio iva 0.489932	CLICK HERE
1927	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.	siguientes procedimientos 0.539535 células madre 0.949818 estadio iv 0.500925 adultos jóvenes 0.452563 órgano cercano.ampliar linfoma 0.561365 siguientes elementos 0.448931 sudores nocturnos 0.484622 faja ajustadora 0.430459 siguientes especialistas 0.43177 siguientes tipos 0.443725 vía oral 0.419326 rayos x 0.473568 Hodgkin Lymphoma 0.582459 abdomen).ampliar linfoma 0.535694 detecte.ampliar exploración 0.434601 enlace drugs approved 0.498183 escáner tep 0.492453 niño ayuda 0.424524 estadio iiies 0.760474 riesgo intermedio 0.462626 efectos tardíos 0.664689 estadio ie 0.575058 células anormales.ampliar aspiración 0.485872	PDQ Efectos tardíos 0.461638 National Cancer Institute 0.420283 sustancia quizás 0.427861 siguientes lugares 0.433237 siguientes riesgos 0.418851 Instituto Nacional 0.434896 PDQ Tratamiento 0.682769 estadio iie 0.500587 Hodgkin recién 0.557678 explorador tep 0.443167 estadio e 0.45134 nuevos tipos 0.421275 Physician Data Query 0.471298 posibles efectos 0.420063 infancia quizás 0.428464 estadio iiis 0.959473 ósea fabrica glóbulos 0.493208 pelvis.ampliar imágenes 0.420331 distinta intensidad 0.419212 almacena células 0.485736 siguientes pruebas 0.485604 siguientes estadios 0.440037	CLICK HERE
1933	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de cáncer de seno (mama) en el embarazo.	estadio lllC 0.545921 procedimientos quizás 0.519027 estadio iv 0.622294 siguientes aspectos 0.528664 secciones llamadas lóbulos 0.542754 estadio lllB 0.547235 estadio lllA 0.548629 estadios ia 0.51696 ganglio linfático centinela 0.983407 Oncotype DX 0.522717 rayos x 0.518956 estadio ib 0.594193 prueba ayuda 0.551927 estadio ia 0.593122 pezón afección 0.529911 enlace drugs approved 0.522117 mama.ampliar cirugía 0.515861 causó hinchazón 0.517244 National Cancer Institute 0.51629 cuántos genes 0.520169	siguientes riesgos 0.513473 realidad células 0.541214 Instituto Nacional 0.528985 cuáles lesiones 0.51826 estadio iiia 0.547361 PDQ Tratamiento 0.523188 estadio iiic 0.745067 cáncer.ampliar mamografía 0.525478 estadio iia 0.550898 estadio llB 0.548944 estadio llA 0.550289 cuánta proteína 0.522295 siguientes casos 0.520535 Physician Data Query 0.558856 carcinoma lobulillar 0.602006 siguientes partes 0.548502 Breast Cancer 0.511799 mamas.ampliar carcinoma lobulillar 0.536157 siguientes pruebas 0.564002 vasos sanguíneos 0.630183	CLICK HERE
2078	National Cancer Institute	Html	es	Tomografía computarizada (TC) y exploraciones para cáncer	Hoja informativa sobre el procedimiento y tecnología de la TC y sus usos para examen de detección, diagnóstico y tratamiento del cáncer. Hoja informativa 5.2s del Instituto Nacional del Cáncer.	imágenes llamada fdg 0.212869 hallazgos anómalos 0.149049 Pediatric Computed Tomography 0.196499 persona promedio 0.156787 Retrieved July 0.224181 rayos x 0.774234 from ct scans 0.197405 ACR Appropriateness Criteria® 0.187415 Patient Safety 0.146744 Low Levels 0.215439 Radiation Risks from 0.30681 radiation dose 0.305638 health care providers 0.311726 Lung Screening Trial 0.175719 risks from 0.542401 Assess Health Risks 0.201898 Retrieved June 0.147049 Exposición Innecesaria 0.154118 Internal Medicine 0.215735 Estados Unidos 0.457591 PubMed Abstract 0.688591 from ct 0.241742 mejores imágenes 0.190153 Cancer Imaging Program 0.180886 SEER Cancer Statistics 0.179794	Reducing Radiation from 0.255009 New Hampshire Avenue 0.163654 radiation risks 0.481539 alto riesgo 0.166125 Drug Administration 0.216737 British Medical Journal 0.160951 retrospective cohort study 0.171194 Mi Historia Médica 0.162596 lifetime attributable risk 0.182458 American College 0.194044 National Cancer Institute 0.177442 Health Risks from 0.371263 baja dosis 0.918737 dosis anual promedio 0.421854 from diagnostic imaging 0.192917 arteriopatía coronaria 0.148972 computed tomography 0.455191 Ionizing Radiation 0.294632 risks from exposure 0.389205 National Research Council 0.163031 pequeños riesgos 0.152571 Colegio Americano 0.296344 Estudio Nacional 0.328775 Sociedad Radiológica 0.211562	CLICK HERE